Clinical trial · Interventional
Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children
Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children: Evaluation of Two Dose Combinations
NCT00405522CI-TRIAL-00037502completedPhase 3Results postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this study is to compare intraoperative and recovery parameters in patients who receive two different dose combinations of propofol and remifentanil in patients undergoing a lumbar puncture.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Spinal Puncture | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Propofol 2.0 mg/kg + Remifentanil 1.5 ug/kg | Drug | — | UNRESOLVED |
| Propofol 4.0 mg/kg + Remifentanil 0.5 ug/kg | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Propofol 2.0 mg/kg + Remifentanil 1.5 ug/kg
- interventionNames
- Drug: Propofol 2.0 mg/kg + Remifentanil 1.5 ug/kg
- type
- EXPERIMENTAL
- label
- Propofol 4.0 mg/kg + Remifentanil 0.5 ug/kg
- interventionNames
- Drug: Propofol 4.0 mg/kg + Remifentanil 0.5 ug/kg
Primary outcomes (2)
- measure
- Duration of Apnea
- timeFrame
- This outcome was measured for the duration of the procedure (lumbar puncture).
- description
- Duration of no respiratory effort
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 3 Years
- Maximum age
- 12 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of a hemato-oncological disorder * Scheduled to undergo a lumbar puncture * Aged 3-12 years * Unpremedicated Exclusion Criteria: * children who are known or suspected to be difficult to ventilate by face mask * children who are deemed medically unfit to receive either of the two study medications * children who are obese (weight for height \> 95th percentile) * children who do not have an indwelling intravenous line
References
Publications (0)
Data not yet available
No reference posted for this study.